IBDEI1KS ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26353,1,3,0)
 ;;=3^Keratoconus,Left Eye,Unspec
 ;;^UTILITY(U,$J,358.3,26353,1,4,0)
 ;;=4^H18.602
 ;;^UTILITY(U,$J,358.3,26353,2)
 ;;=^5005090
 ;;^UTILITY(U,$J,358.3,26354,0)
 ;;=H18.603^^130^1288^23
 ;;^UTILITY(U,$J,358.3,26354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26354,1,3,0)
 ;;=3^Keratoconus,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,26354,1,4,0)
 ;;=4^H18.603
 ;;^UTILITY(U,$J,358.3,26354,2)
 ;;=^5005091
 ;;^UTILITY(U,$J,358.3,26355,0)
 ;;=H18.9^^130^1288^5
 ;;^UTILITY(U,$J,358.3,26355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26355,1,3,0)
 ;;=3^Cornea Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,26355,1,4,0)
 ;;=4^H18.9
 ;;^UTILITY(U,$J,358.3,26355,2)
 ;;=^5005132
 ;;^UTILITY(U,$J,358.3,26356,0)
 ;;=H10.9^^130^1288^4
 ;;^UTILITY(U,$J,358.3,26356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26356,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,26356,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,26356,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,26357,0)
 ;;=H11.233^^130^1288^26
 ;;^UTILITY(U,$J,358.3,26357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26357,1,3,0)
 ;;=3^Symblepharon,Bilateral
 ;;^UTILITY(U,$J,358.3,26357,1,4,0)
 ;;=4^H11.233
 ;;^UTILITY(U,$J,358.3,26357,2)
 ;;=^5004775
 ;;^UTILITY(U,$J,358.3,26358,0)
 ;;=H11.231^^130^1288^28
 ;;^UTILITY(U,$J,358.3,26358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26358,1,3,0)
 ;;=3^Symblepharon,Right Eye
 ;;^UTILITY(U,$J,358.3,26358,1,4,0)
 ;;=4^H11.231
 ;;^UTILITY(U,$J,358.3,26358,2)
 ;;=^5004773
 ;;^UTILITY(U,$J,358.3,26359,0)
 ;;=H11.232^^130^1288^27
 ;;^UTILITY(U,$J,358.3,26359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26359,1,3,0)
 ;;=3^Symblepharon,Left Eye
 ;;^UTILITY(U,$J,358.3,26359,1,4,0)
 ;;=4^H11.232
 ;;^UTILITY(U,$J,358.3,26359,2)
 ;;=^5004774
 ;;^UTILITY(U,$J,358.3,26360,0)
 ;;=H04.121^^130^1288^13
 ;;^UTILITY(U,$J,358.3,26360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26360,1,3,0)
 ;;=3^Dry Eye Syndrome,Right Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,26360,1,4,0)
 ;;=4^H04.121
 ;;^UTILITY(U,$J,358.3,26360,2)
 ;;=^5004463
 ;;^UTILITY(U,$J,358.3,26361,0)
 ;;=H04.122^^130^1288^12
 ;;^UTILITY(U,$J,358.3,26361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26361,1,3,0)
 ;;=3^Dry Eye Syndrome,Left Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,26361,1,4,0)
 ;;=4^H04.122
 ;;^UTILITY(U,$J,358.3,26361,2)
 ;;=^5004464
 ;;^UTILITY(U,$J,358.3,26362,0)
 ;;=H04.123^^130^1288^11
 ;;^UTILITY(U,$J,358.3,26362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26362,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,26362,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,26362,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,26363,0)
 ;;=H15.111^^130^1288^16
 ;;^UTILITY(U,$J,358.3,26363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26363,1,3,0)
 ;;=3^Episcleritis Periodica Fugax,Right Eye
 ;;^UTILITY(U,$J,358.3,26363,1,4,0)
 ;;=4^H15.111
 ;;^UTILITY(U,$J,358.3,26363,2)
 ;;=^5004838
 ;;^UTILITY(U,$J,358.3,26364,0)
 ;;=H15.112^^130^1288^15
 ;;^UTILITY(U,$J,358.3,26364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26364,1,3,0)
 ;;=3^Episcleritis Periodica Fugax,Left Eye
 ;;^UTILITY(U,$J,358.3,26364,1,4,0)
 ;;=4^H15.112
 ;;^UTILITY(U,$J,358.3,26364,2)
 ;;=^5004839
 ;;^UTILITY(U,$J,358.3,26365,0)
 ;;=H15.113^^130^1288^14
 ;;^UTILITY(U,$J,358.3,26365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26365,1,3,0)
 ;;=3^Episcleritis Periodica Fugax,Bilateral
 ;;^UTILITY(U,$J,358.3,26365,1,4,0)
 ;;=4^H15.113
 ;;^UTILITY(U,$J,358.3,26365,2)
 ;;=^5004840
 ;;^UTILITY(U,$J,358.3,26366,0)
 ;;=T15.02XA^^130^1288^17
